Beyond T Cell Subsets: Stemness and Adaptation Redefining Immunity and Immunotherapy

Targeting stem-like CD4⁺ T cells offers great therapeutic potential: disrupting their persistence could mitigate autoimmune pathology and transplant rejection, whereas enhancing their effector capacity could improve antitumor immunity.